DISINFECTION-TABLETS- hocl solution

Disinfection-Tablets by

Drug Labeling and Warnings

Disinfection-Tablets by is a Otc medication manufactured, distributed, or labeled by Jinhua Shuxin Pharmaceutical Biotechnology Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

SPL UNCLASSIFIED SECTION

Disinfection Tablets

Active Ingredient(s)

HOCL 80% w/w. Purpose: Antiseptic

Purpose

Antiseptic, Disinfection Tablets

Use

Disinfection Tablets to help reduce bacteria that potentially can cause disease.

Warnings

For external use only.

Do not use

• in children less than 2 months of age
• on open skin wounds

WHEN USING

When using this product keep out of eyes, ears, and mouth. In case of contact with eyes, rinse eyes thoroughly with water.
Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

STOP USE

Stop use and ask a doctor if irritation or rash occurs. These may be signs of a serious condition.

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

• Simply drop 1 tablet into 17 fl oz(500mL) of clean water. Let the tablet dissolve to form the sterilising solution. Spray on the skin 3-5 times each use. No rinsing reqiured.

Other information

• Store between 15-30C (59-86F)

Inactive ingredients

SODIUM CHLORIDE

Package Label - Principal Display Panel

INGREDIENTS AND APPEARANCE

DISINFECTION-TABLETS 
hocl solution

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 82377-301
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
HYPOCHLOROUS ACID (UNII: 712K4CDC10) (HYPOCHLOROUS ACID - UNII:712K4CDC10)	HYPOCHLOROUS ACID	0.8 mg  in 1 mg

Inactive Ingredients
Ingredient Name	Strength
SODIUM CHLORIDE (UNII: 451W47IQ8X)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 82377-301-01	6 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
2	NDC: 82377-301-02	8 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
3	NDC: 82377-301-03	10 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
4	NDC: 82377-301-04	12 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
5	NDC: 82377-301-05	24 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
6	NDC: 82377-301-06	30 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
7	NDC: 82377-301-07	40 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
8	NDC: 82377-301-08	50 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
9	NDC: 82377-301-09	60 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021
10	NDC: 82377-301-10	100 mg in 1 BOTTLE; Type 0: Not a Combination Product	11/04/2021

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		11/04/2021

Labeler - Jinhua Shuxin Pharmaceutical Biotechnology Co., Ltd. (541278228)

Establishment
Name	Address	ID/FEI	Business Operations
Jinhua Shuxin Pharmaceutical Biotechnology Co., Ltd.		541278228	manufacture(82377-301)